COVID-19 and the Liver: SARS-COV-2 Diagnostic Testing and Vaccine Development
On July 9, AASLD hosted a webinar where speakers discussed the different testing modalities for SARS-COV-2, the virus that...
HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy
Mauricio Lisker‐Melman, Abdus S. Wahed, Marc G. Ghany, Raymond T. Chung, Wendy C. King, David E. Kleiner, Atul K. Bhan, Mandana Khalili, Mamta K. Jain, Mark Sulkowski, David K. Wong, Gavin Cloherty, Richard K. Sterling – 29 June 2022
Long‐term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States
Peter Lymberopoulos, Sameer Prakash, Anjiya Shaikh, Anshul Bhatnagar, Anthony K. Allam, Karthik Goli, John A. Goss, Fasiha Kanwal, Abbas Rana, Kris V. Kowdley, Prasun Jalal, George Cholankeril – 29 June 2022 – There have been conflicting data regarding liver transplantation (LT) outcomes for hereditary hemochromatosis (HH), with no recent data on LT outcomes in patients with HH in the past decade. Using the United Network for Organ Sharing registry, we evaluated waitlist and post‐LT survival in all adult patients listed for HH without concomitant liver disease from 2003 to 2019.